Immune competence after alemtuzumab treatment of multiple sclerosis.

Immune competence after alemtuzumab treatment of multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37451106
Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalitiesAlemtuzumab in Multiple Sclerosis: Mechanism of Action and BeyondAlemtuzumab for Multiple Sclerosis.Alemtuzumab for the treatment of multiple sclerosisAlemtuzumab for the treatment of relapsing-remitting multiple sclerosis: a review of its clinical pharmacology, efficacy and safety.Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts.Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab.Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer.Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis.Alemtuzumab: a review of its use in patients with relapsing multiple sclerosis.Drug safety evaluation of alemtuzumab for multiple sclerosis.Alemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis.Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents.Vaccines in Multiple Sclerosis.[Guidelines for vaccination of immunocompromised individuals].Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.
P2860

Immune competence after alemtuzumab treatment of multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37451106
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune competence after alemtuzumab treatment of multiple sclerosis.
@en
Immune competence after alemtuzumab treatment of multiple sclerosis.
@nl
type
label
Immune competence after alemtuzumab treatment of multiple sclerosis.
@en
Immune competence after alemtuzumab treatment of multiple sclerosis.
@nl
prefLabel
Immune competence after alemtuzumab treatment of multiple sclerosis.
@en
Immune competence after alemtuzumab treatment of multiple sclerosis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Immune competence after alemtuzumab treatment of multiple sclerosis.
@en
P2093
P2860
P304
P31
P356
10.1212/WNL.0B013E3182A35215
P407
P433
P478
P577
P698
P921
P932